explore -WSS

explore

author：fashion 2025-08-12 06:45:26 - browse：13712

UCB website -- health policy coverage from STAT — Adobe

WASHINGTON — UCB left BIO at the end of 2023, the second major member company to exit after Pfizer pulled out as well.

UCB, headquartered in Belgium, decided not to renew its BIO membership after a routine evaluation of its engagement in trade associations, said company spokesperson Erica Puntel.

Newsletters

Sign up for D.C. Diagnosis

Washington never stops. Cut through the noise with our essential updates on health care politics and policy

Please enter a valid email address. Privacy Policy

Pfizer, whose departure STAT reported first, was listed on BIO’s website as a sponsor at one of the group’s highest levels. Pfizer bought Global Blood Therapeutics, which current BIO Board Chair Ted Love led to the approval of a drug to treat sickle cell disease, in 2022.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Psilocybin's anti

WSS

Complete sequence of Y chromosome published for first time

Feds fine Medicare Advantage plans for overcharging members

Winners, losers from Medicare’s list of drugs subject to price talks

Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

Fauci’s Covid grilling leads GOP to weigh foreign research rules

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

entertainment

explore

Sign up for D.C. Diagnosis

explore

Duchenne breakthrough therapy leaves behind pioneering families

Fauci’s Covid grilling leads GOP to weigh foreign research rules

At least 13 dead in Texas as scorching temps continue

2024 GOP presidential candidates spar over abortion in debate

Alkermes shareholders re

Appeals court upholds limits to abortion pill

The cancer drug shortage isn’t new — and neither are the solutions

HHS names first

Supreme Court strikes down use of affirmative action

Health and fitness trackers are measuring the wrong things

entertainment

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

GSK to buy asthma

New menopause drug shows promise in relief for hot flashes

Generative AI mines health records to identify patients’ social needs

DeSantis can now import cheaper drugs. But will Biden get credit?

As JPM 2024 winds down, some health tech firms project optimism

leisure time

focus

hotspot

Wikipedia